Skip to main navigation Skip to search Skip to main content

A Pivotal, Multicenter, Double-Blind Study of the Safety and Effectiveness of Synvisc-One (hylan G-F 20) in Patients with Mild to Moderate Primary Osteoarthritis of the Hip

Project: Research

Project Details

StatusFinished
Effective start/end date01/3/13 → 10/3/22

Funding

  • Genzyme Corporation: $51,827.00